Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions
2018
The MR-Base platform supports systematic causal inference across the human phenome
2018 Standout
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
2018
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
2014
In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
2018 Standout
Biological roles of glycans
2016 Standout
The Genetic Architecture of the Human Immune System: A Bioresource for Autoimmunity and Disease Pathogenesis
2015
Neuroteratogenic Viruses and Lessons for Zika Virus Models
2016
Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a ‘high-affinity’ FcγRIIa genotype
2010
Exosomes: biogenesis, biologic function and clinical potential
2019 Standout
Immunopathology of multiple sclerosis
2015 Standout
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
2010 StandoutNobel
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
2011 StandoutNobel
Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function
2014
Exosomes in human semen restrict HIV-1 transmission by vaginal cells and block intravaginal replication of LP-BM5 murine AIDS virus complex
2015
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
2015
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
Is developing an HIV-1 vaccine possible?
2010
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Role of adjuvants in modeling the immune response
2010
Mucosal Immunity and Protection Against HIV/SIV Infection: Strategies and Challenges for Vaccine Design
2009
Immunological correlates of protection from HIV infection and disease
2006
The spread, treatment, and prevention of HIV-1: evolution of a global pandemic
2008
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
A Bispecific Antibody Composed of a Nonneutralizing Antibody to the gp41 Immunodominant Region and an Anti-CD89 Antibody Directs Broad Human Immunodeficiency Virus Destruction by Neutrophils
2008
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
New paradigms for functional HIV-specific nonneutralizing antibodies
2013
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
2023 StandoutNobel
The role of Fc–FcγR interactions in IgG-mediated microbial neutralization
2015
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Colonization by Pneumocystis jirovecii and Its Role in Disease
2012
Hidden Killers: Human Fungal Infections
2012 Standout
Correlates of Protection Induced by Vaccination
2010 Standout
Glyco-seek: Ultrasensitive Detection of Protein-Specific Glycosylation by Proximity Ligation Polymerase Chain Reaction
2016 StandoutNobel
Works of Tran B. Phan being referenced
FcγRIIa Genotype Predicts Progression of HIV Infection
2007
Antibody inhibition of cytomegalovirus: the role of natural killer and macrophage effector cells
2001
The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells
2013
IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation
2011
Recombinant gp120 Vaccine-Induced Antibodies Inhibit Clinical Strains of HIV-1 in the Presence of Fc Receptor-Bearing Effector Cells and Correlate Inversely with HIV Infection Rate
2007
Interactions between Natural Killer Cells and Antibody Fc Result in Enhanced Antibody Neutralization of Human Immunodeficiency Virus Type 1
2005
Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects
2016